Aerobic Vaginitis
Study: Intravaginal kanamycin more effective treatment than meclocycline
Published in OBGYN and Reproduction Week, August 23rd, 2004
"The term 'aerobic vaginitis' defines a 'new' vaginal pathology that is neither classifiable as specific vaginitis nor as bacterial vaginosis. We studied a sample of 30 women with a clinical and microbiological diagnosis of aerobic vaginitis and compared the efficacy and tolerability of kanamycin and meclocycline, two products commercially available in Italy in the form of vaginal pessaries," said G. Tempera and colleagues, University of Catania, Italy.
Patients were administered one pessary per day for 6 days of either kanamycin or...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of OBGYN and Reproduction Week
More Articles from OBGYN and Reproduction Week
- Hormone Replacement Therapy
Menopause experts in Europe issue statement on postmenopausal HRT - Hormone Replacement Therapy
WHI conclusions on HRT-associated endometrial cancer risk questioned - Human Papillomavirus
HPV vaccine targets women age 24-45 - Obstetrics
Small delay in delivery improves risk of disability for very premature babies - Reproductive Biology
Researchers identify immunologic mechanism essential for pregnancy success - Assisted Reproduction
HLA-G genotype associated with unsuccessful IVF and pregnancy outcome - More from this issue of OBGYN and Reproduction Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
